However, by conducting power and sample size calculation 47, our study assessed MCL1 CNVs in 516 NSCLC patients, achieving a power of 0.964 to detect the potentially clinical significant differences in OS. The gene discussed is MCL1; the disease is non-small cell lung carcinoma.